Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001980549 | SCV002271541 | uncertain significance | not provided | 2023-03-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects CFI function (PMID: 32510551, 35531992). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CFI protein function. ClinVar contains an entry for this variant (Variation ID: 1489275). This missense change has been observed in individual(s) with hemolytic uremic syndrome (PMID: 35619721). This variant is present in population databases (rs377528991, gnomAD 0.0009%). This sequence change replaces serine, which is neutral and polar, with tyrosine, which is neutral and polar, at codon 221 of the CFI protein (p.Ser221Tyr). |
Fulgent Genetics, |
RCV002479688 | SCV002783863 | uncertain significance | Atypical hemolytic-uremic syndrome with I factor anomaly; Age related macular degeneration 13; Factor I deficiency | 2022-02-18 | criteria provided, single submitter | clinical testing |